Evidence map›Paper›PMID 32655570›Full record

ArticleFrontiers in immunology2020

Activation of M1 Macrophages in Response to Recombinant TB Vaccines With Enhanced Antimycobacterial Activity.

Shiu-Ju Yang, Yih-Yuan Chen, Chih-Hao Hsu, Chia-Wei Hsu, Chun-Yu Chang, Jia-Ru Chang, Horng-Yunn Dou

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cyclic-di-AMP Phosphodiesterase Elicits Protective Immune Responses AgainstFrontiers in cellular and infection microbiology · 2022
    Article
  12. Article
  13. Article
  14. Endometriosis and Cancer: Exploring the Role of Macrophages.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shiu-Ju YangNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Yih-Yuan ChenDepartment of Biochemical Science and Technology, National Chiayi University, Chia-Yi, Taiwan.
Chih-Hao HsuNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Chia-Wei HsuNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Chun-Yu ChangNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Jia-Ru ChangNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Horng-Yunn DouNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
National Health Research Institutes · TWNational Chiayi University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary tuberculosis (TB) is a difficult-to-eliminate disease. Although the Bacille Calmette-Guérin (BCG) vaccine against

Indexed as

AnimalsBCG VaccineMacrophage ActivationMacrophagesMiceMycobacterium tuberculosisTuberculosis, PulmonaryVaccines, SyntheticBCG VaccineVaccines, Syntheticinnate immunitymacrophageMycobacterium tuberculosisrecombinant Bacille Calmette–Guérinvaccine

Identifiers

PMID32655570
PMCPMC7325470
OpenAlexW4231379103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.